Profilo
Mark Heiman worked as a Principal at Eli Lilly & Co. and as an Assistant Professor at Tulane University.
He was also the Chief Scientific Officer & Vice President-Research at MicroBiome Therapeutics LLC from 2013 to 2018.
He received his undergraduate degree from the University of New Orleans and his doctorate from LSU Medical School.
Precedenti posizioni note di Mark Heiman
| Società | Posizione | Fine |
|---|---|---|
MicroBiome Therapeutics LLC
 MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Direttore Tecnico/Scientifico/R&S | 02/01/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| Tulane University (Louisiana) | Corporate Officer/Principal | - |
Formazione di Mark Heiman
| University of New Orleans | Undergraduate Degree |
| Lsu Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 1 |
|---|---|
MicroBiome Therapeutics LLC
MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Health Technology |
- Borsa valori
- Insiders
- Mark Heiman
